Statistics for Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA
Total visits
views | |
---|---|
Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA | 30 |
Total visits per month
views | |
---|---|
July 2024 | 2 |
August 2024 | 2 |
September 2024 | 3 |
October 2024 | 2 |
November 2024 | 2 |
December 2024 | 6 |
January 2025 | 0 |
File Visits
views | |
---|---|
Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant_a study based on molecular docking, molecular dynamics.pdf(legacy) | 1 |
Top country views
views | |
---|---|
United States | 10 |
China | 7 |
Australia | 5 |
Portugal | 4 |
Brazil | 1 |
Canada | 1 |
India | 1 |
Mongolia | 1 |